Study to Evaluate Efficacy and Safety of Mepolizumab for Frequently Exacerbating Chronic Obstructive Pulmonary Disease (COPD) Patients
Condition(s):Pulmonary Disease, Chronic ObstructiveLast Updated:August 31, 2018Completed
Hide Studies Not Open or Pending
Condition(s):Pulmonary Disease, Chronic ObstructiveLast Updated:August 31, 2018Completed
Condition(s):Pulmonary Disease, Chronic ObstructiveLast Updated:August 16, 2018Completed
Condition(s):Chronic Rhinosinusitis With Nasal Polyps; Asthma; Eosinophilic; EosinophiliaLast Updated:July 12, 2023Recruiting
Condition(s):Churg Strauss SyndromeLast Updated:June 15, 2012Completed
Condition(s):Nasal PolypsLast Updated:April 12, 2021Completed
Condition(s):Hypereosinophilia; Hypereosinophilic SyndromeLast Updated:May 5, 2020Completed
Condition(s):Hypereosinophilic SyndromeLast Updated:November 25, 2020No longer available
Condition(s):Churg-Strauss SyndromeLast Updated:September 21, 2022Active, not recruiting
Condition(s):Severe Eosinophilic AsthmaLast Updated:November 13, 2018Unknown status
Condition(s):Severe Eosinophilic AsthmaLast Updated:September 12, 2019Unknown status
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.